12422001

Source:http://linkedlifedata.com/resource/pubmed/id/12422001

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0038013, umls-concept:C0205269, umls-concept:C0666743, umls-concept:C1274040, umls-concept:C2603343
pubmed:issue	11
pubmed:dateCreated	2002-11-7
pubmed:abstractText	To evaluate the efficacy and safety of a loading regimen of the anti-tumour necrosis factor alpha (TNF-alpha) antibody infliximab in predominantly axial severe ankylosing spondylitis (AS).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100883501
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1462-0324
pubmed:author	pubmed-author:AlexandruSS, pubmed-author:BrebanMM, pubmed-author:ClaudepierrePP, pubmed-author:DevauchelleVV, pubmed-author:DougadosMM, pubmed-author:Euller-ZieglerLL, pubmed-author:LespessaillesEE, pubmed-author:MezièresMM, pubmed-author:PerdrigerAA, pubmed-author:SibiliaJJ, pubmed-author:VignonEE, pubmed-author:WendlingDD
pubmed:issnType	Print
pubmed:volume	41
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1280-5
pubmed:dateRevised	2007-9-6
pubmed:meshHeading	pubmed-meshheading:12422001-Adult, pubmed-meshheading:12422001-Aged, pubmed-meshheading:12422001-Analysis of Variance, pubmed-meshheading:12422001-Antibodies, Monoclonal, pubmed-meshheading:12422001-Dose-Response Relationship, Drug, pubmed-meshheading:12422001-Drug Administration Schedule, pubmed-meshheading:12422001-Female, pubmed-meshheading:12422001-Follow-Up Studies, pubmed-meshheading:12422001-France, pubmed-meshheading:12422001-Humans, pubmed-meshheading:12422001-Infusions, Intravenous, pubmed-meshheading:12422001-Male, pubmed-meshheading:12422001-Middle Aged, pubmed-meshheading:12422001-Probability, pubmed-meshheading:12422001-Prospective Studies, pubmed-meshheading:12422001-Severity of Illness Index, pubmed-meshheading:12422001-Spondylitis, Ankylosing, pubmed-meshheading:12422001-Statistics, Nonparametric, pubmed-meshheading:12422001-Time Factors, pubmed-meshheading:12422001-Treatment Outcome
pubmed:year	2002
pubmed:articleTitle	Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study.
pubmed:affiliation	Institut de Rhumatologie, Hôpital Cochin, Université René Descartes, Paris, France.
pubmed:publicationType	Journal Article, Clinical Trial, Multicenter Study